Oasmia Pharmaceutical AB (Nasdaq: OASM) has announced the appointment of Fredrik Gynnerstedt to the position of Chief Financial Officer (CFO).Fredrik ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE